Publication: 360

Publication: 360

Doxorubicin, vinblastine and gemcitabine (AVG), a novel regimen excluding bleomycin for the treatment of early stage Hodgkin Lymphoma (HL): Results of CALGB 50203

URL

Google Scholar

Citation:: Blood vol 110 (11) abstr 214

Year:: 2007
Type:: Abstract
Sub type:: Poster General
Funding:: NCTN
Endpoint:: Primary
Analysis:: Primary
Data Sharing:: No-Data-Sharing
Status:: Presented/Published
Citation Status:: pub

Note:

Methodological:: No
Biospecimen:: No
SDC:: No

Parents:: None
Children:: 130

Program:: OGC
Primary Committee:: Lymphoma
Sec. Committees:

Pharmas:
Grants:

Corr. Author:
Authors:: D. J. Straus A. S. Lacasce M. E. Juweid L. Kostakoglu N. C. Hall J. L. Johnson S. Jung G. P. Canellos L. Schwartz B. D. Cheson

Networks:

Study: CALGB-50203
Multiple Studies, or Legacy Studies in Alliance Study:
Phases:: 2

Keywords: